What is Fiasp FlexTouch?
Fiasp FlexTouch is a brand of insulin aspart, a rapid-acting human insulin analogue used to manage diabetes mellitus. It helps control blood sugar levels after meals and during periods of increased glucose production. Fiasp FlexTouch contains 100 units/mL of insulin aspart and has a pH-adjusted formulation for improved stability. The FlexTouch pen device allows for easy administration in doses ranging from 1-60 units per injection, with a maximum dose not to exceed 6 units per kilogram body weight per day.
What is Fiasp FlexTouch used for?
Fiasp FlexTouch is a branded formulation of insulin faspro, which is a rapid-acting human insulin analog. It was developed by Novo Nordisk and approved by the US FDA in 2017 for the treatment of diabetes mellitus. Fiasp FlexTouch is a flexible pen device that contains a concentrated solution of insulin faspro, which is designed to provide a rapid onset and peak action.
The FlexTouch mechanism allows users to adjust their dose and volume with ease using a spring-loaded needle protection system, making it easier for patients to manage their diabetes treatment. Insulin faspro, the active ingredient in Fiasp FlexTouch, is produced through recombinant DNA technology and has been engineered to have a faster onset of action compared to traditional human insulin. This allows for more effective postprandial glucose control in type 1 and 2 diabetic patients.
Fiasp FlexTouch is administered via subcutaneous injection and provides an insulin activity duration of approximately 4-5 hours, which supports the maintenance of blood glucose levels within a target range. It can be used in combination with other diabetes medications or insulin products as part of a comprehensive treatment regimen under the guidance of a healthcare provider.
Important Information
It is essential for patients using Fiasp FlexTouch to follow the prescribed dosing instructions carefully and adjust their insulin regimens based on individual glucose monitoring results. Regular blood glucose monitoring, dietary modifications, and regular exercise are also critical components of effective diabetes management with Fiasp FlexTouch.
Fiasp FlexTouch side effects
- Injection site reactions (e.g., redness, swelling, itching, pain)
- Hypoglycemia
- Allergic reactions
- Infections at the injection site
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Muscle or back pain
- Headache
- Fatigue
Disclaimer
The content on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided here is based on general research and may not apply to individual circumstances. We do not guarantee the accuracy or completeness of any content on this website. Always consult with a healthcare professional before making any changes to your medication or health routine.